Yohimbine treatment reverses type 2
20th October 2014
Researchers have used a restricted a2A-adrenergic receptor antagonist to reverse type 2 diabetes in people whose condition is linked to a common genetic variant.
Log In
Welcome to AusDoc.Plus, the new home of Australian Doctor, Medical Observer, 6minutes and How to Treat. You can use your existing login credentials for any of these sites to gain entry.
Not a member?
Join AusDoc.PLUS
Register
To ensure you get the right membership, please select your vocation: